Semaglutide 12.5mg Multi-Dose Vial
Apollo Care recalls semaglutide 12.5mg vials due to particulate matter.
Stop using the recalled semaglutide vials immediately and contact your healthcare provider for guidance. Return the product to the place of purchase or follow the firm's instructions for disposal.
Why it was recalled
Apollo Care is recalling semaglutide 12.5mg (2.5mg/mL) 5 mL sterile multi-dose vials due to the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material. Use of the affected product may pose a risk of adverse reactions.
Is mine affected?
This recall covers 11 products. Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
SEMAGLUTIDE
| Lot code | Strength | NDC / UPC | Recall # |
|---|---|---|---|
| AC-017273, 2026 | 7.5 mg | NDC 71170-721-01 | D-0755-2026 |
| AC-017108, 2026 | 12.5 mg | NDC 71170-495-05 | D-0747-2026 |
| AC-017271, 2026 | 2.5 mg | NDC 71170-711-02 | D-0753-2026 |
| AC-017114, 2026 | 2.25 mg | NDC 71170-811-02 | D-0748-2026 |
| AC-017131, 2026 | 0.9 mg | NDC 71170-810-01 | D-0752-2026 |
| C-017115, 2026 | 6.75 mg | NDC 71170-821-01 | D-0749-2026 |
| AC-017125, 2026 | 9 mg | NDC 71170-822-02 | D-0751-2026 |
| AC-017274, 2026 | 10 mg | NDC 71170-722-02 | D-0756-2026 |
Show all 11 products
| Lot code | Strength | NDC / UPC | Recall # |
|---|---|---|---|
| AC-017275, 2026 | 20 mg | NDC 71170-724-04 | D-0757-2026 |
| AC-017124, 2026 | 4.5 mg | NDC 71170-812-03 | D-0750-2026 |
| AC-017272, 2026 | 5 mg | NDC 71170-712-03 | D-0754-2026 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Foreign Material recalls
Editorial summary by Recall Canary · summary updated 2026-09-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification